Why the study?
Does acute intravenous verapamil alter cardiovascular function in patients with and without ischemic heart disease?
Population
52 patients (29 with ischemic heart disease and 23 without heart disease)
Design
Cohort
Follow-up
acute
Authors
Loading...
Supports potential hemodynamic safety of acute IV verapamil in IHD without contractility depression; hypothesis-generating and leaves open need for randomized confirmation.
Does acute intravenous verapamil alter cardiovascular function in patients with and without ischemic heart disease?
Acute intravenous verapamil is safe and does not depress myocardial contractility in patients with ischemic heart disease.
Vincenzi et al. (1981) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: